Birchview Capital »

Nektar Therapeutics shares owned by Birchview Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Birchview Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $17k 28k 0.60
2023-06-30 $16k 28k 0.58
2023-03-31 $83k 118k 0.70
2022-12-31 $267k 118k 2.26
2022-09-30 $410k 128k 3.20
2022-06-30 $486k 128k 3.80
2022-03-31 $690k 128k 5.39
2021-12-31 $1.4M 100k 13.51
2021-09-30 $1.3M 72k 17.96
2021-06-30 $1.2M 72k 17.17
2021-03-31 $1.8M 92k 20.00
2019-06-30 $338k 9.5k 35.58
2019-03-31 $319k 9.5k 33.58
2018-12-31 $312k 9.5k 32.84
2018-09-30 $579k 9.5k 60.95
2018-06-30 $464k 9.5k 48.84